GE HealthCare profit beats estimates on strong U.S. and EMEA demand
GE HealthCare Technologies (NASDAQ:GEHC) delivered a strong finish to 2025, reporting fourth-quarter sales that outpaced expectations and providing a 2026 forecast that signals continued margin expansion for the medical-tech giant.







-640x358.jpg&w=3840&q=75)


